InsidersTradesSigma
Follow the Jade Biosciences, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €883m. The latest transaction was filed on 13 February 2026 (Attribution). Among the most active insiders: Frohlich Tom. All data is openly available.
Analysts rate Jade Biosciences, Inc. Strong Buy (bullish), based on 7 analysts. Average price target: US$49.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
Jade Biosciences, Inc. is a company listed on the XNAS market, specializing in the development of biopharmaceutical solutions. It focuses on innovation in the life sciences sector.